Skip to main content
logo
Cyclerion Therapeutics, Inc. (CYCN)
NASDAQ: CYCN · Real-Time Price · USD
3.680
+0.190 (5.44%)
Aug 4, 2026, 2:43 PM EDT - Market open

Cyclerion Therapeutics Financials Overview

Millions USD. Fiscal year is Jan - Dec.

Revenue & Profits
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Revenue
1.992.072-0.33.94
Revenue Growth
-4.23%3.70%---92.47%71.69%
Gross Profit
1.992.072-0.33.94
Operating Income
-6.73-4.97-3.63-12.95-18.54-55.2
Net Income
-5.28-3.53-3.06-5.26-44.08-51.65
Earnings Per Share
-1.36-1.11-1.21-2.25-8.40-26.40
EPS Growth
------

Cash & Debt
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash & Investments
2.823.243.237.5713.3853.96
Total Debt
000000
Net Cash (Debt)
2.823.243.237.5713.3853.96
Net Cash Growth
-22.42%0.25%-57.31%-43.42%-75.20%523.11%
Net Cash Per Share
0.561.021.283.246.1627.57

Cash Flow & CapEx
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Operating Cash Flow
-3.52-3.31-4.33-21.25-40.61-36.52
Capital Expenditures
-0.07-----0.01
Free Cash Flow
-3.59-3.31-4.33-21.25-40.61-36.52
Free Cash Flow Growth
------

Margins
Chart
Fiscal YearTTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingMar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Gross Margin
100.00%100.00%100.00%-100.00%100.00%
Operating Margin
-337.43%-239.78%-181.40%--6242.42%-1400.18%
Pretax Margin
-264.73%-170.11%-152.85%--6143.43%-1310.17%
Profit Margin
-264.73%-170.11%-152.85%--6143.43%-1310.17%
FCF Margin
-180.03%-159.79%-216.65%--13673.70%-926.53%

Valuation
Chart
Fiscal YearCurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period EndingAug '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PS Ratio
7.432.344.10-96.1218.94